InVivo Therapeutics (NSDQ:NVIV) today registered for an upcoming offering, looking to raise approximately $8 million, according to an SEC filing.
In the offering, the Cambridge, Mass.-based company will look to offer shares of common stock and Series A warrants.
The offering is slated to include a 45-day underwriter’s option for the purchase of additional shares, according to an SEC filing
InVivo Therapeutics has not yet stated how many shares it plans to offering the round, or at what rate it will be offering shares and warrants.
Earlier this month, InVivo pulled the trigger on a 1-for-25 reverse split of its stock, looking to put a single share in the hands of its shareholders for every 25 shares they previously owned.
The post InVivo Therapeutics registers $8m offering appeared first on MassDevice.
from MassDevice https://ift.tt/2HZqf5i
Cap comentari:
Publica un comentari a l'entrada